Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

7.700 +1.020 (+15.27%)

Streaming Delayed Price Updated: 12:22 PM EDT, Apr 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Nu Holdings, Ally Financial And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 16, 2022

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares rose 17.5% to $4.10 in pre-market trading after the company said Q2 sales results were up year over year and raised FY22 sales guidance above...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 16, 2022

It's time for an overview of the biggest pre-market stock movers for Tuesday and the news that's affecting them this morning.

Via InvestorPlace

Why IZEA Worldwide Shares Are Trading Higher By Over 30%: Here Are 37 Stocks Moving Premarket ↗

August 16, 2022

Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) shares rose 30.8% to $1.19 in pre-market trading after the company reported a second-quarter revenue increase of 96% year-over-year to $12.58 million,...

Via Benzinga

Cronos Group Q2 Net Revenue Loss Reduced By 38% ↗

August 10, 2022

Cronos Group Inc. announced its Q2 2022 business results for the period ending June 30th, 2022, on Wednesday.

Via Talk Markets

Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock Deal ↗

July 25, 2022

Via Benzinga

Why Cathie Wood Favorite Ginkgo Bioworks Is Surging After Hours ↗

August 15, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher in Monday's after-hours session after the company reported strong financial results and raised full-year guidance above analy

Via Benzinga

Looking Into Ginkgo Bioworks Holdings Recent Short Interest ↗

August 15, 2022

Ginkgo Bioworks Holdings (NYSE:DNA) short percent of float has risen 3.5% since its last report. The company recently reported that it has 150.27 million shares sold...

Via Benzinga

An Airport Spa And Biosecurity Co. Act As "Surveillance" In US Airports As Part Of $60M CDC "Early Warning" Contract For SARS-CoV-2 ↗

August 15, 2022

Via Benzinga

SmileDirectClub (SDC) Stock Gains Despite Weak Q2 Earnings ↗

August 12, 2022

SmileDirectClub (SDC) stock is on the move Friday following the release of its earnings report for the second quarter of 2022.

Via InvestorPlace

What Is Going on With Ginkgo Bioworks (DNA) Stock Today? ↗

August 12, 2022

DNA stock and other small biotech plays are rising on speculation about drugs like its candidate against gout.

Via InvestorPlace

Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket ↗

August 12, 2022

Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange.

Via Benzinga

Earnings Scheduled For August 15, 2022 ↗

August 15, 2022

Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

Via Benzinga

Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday ↗

August 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.

Via Benzinga

What Is Going on With 23andMe (ME) Stock Today? ↗

August 11, 2022

23andMe, Invitae and others are seeing an explosive rally, but investors want to know if ME stock and others can continue to climb.

Via InvestorPlace

Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session ↗

August 11, 2022

Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering.

Via Benzinga

Dow Eyes Another Triple-Digit Win As Sentiment Turns Sunny ↗

August 11, 2022

Stocks are eyeing even more upside this Thursday afternoon.

Via Talk Markets

Cathie Wood Is Doubling Down on Biotech Stocks DNA, NVTA, TDOC ↗

August 11, 2022

Cathie Wood is at it again. The high-growth fund manager bought a number of biotech stocks this week, adding to her sizable holdings.

Via InvestorPlace

Disney, Inotiv, Warby Parker And Some Other Big Stocks Moving Higher On Thursday ↗

August 11, 2022

Absci Corporation (NASDAQ: ABSI) jumped 38.8% to $5.83 after the company reported a narrower Q2 loss.

Via Benzinga

Why Ginkgo Bioworks Stock Is Soaring Today ↗

August 11, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Thursday after Synlogic Inc (NASDAQ: SYBX) announced a new drug candidate for the treatment of gout, which is being developed in...

Via Benzinga

10 Stocks That Could Rise 10x (Safely) ↗

August 10, 2022

There are two ways to find stocks that could rise 10x. Here are those strategies, and 10 stocks you can buy now to profit.

Via InvestorPlace

AMTD Digital and MEGL Stock: Are Meme Stocks Back? ↗

August 09, 2022

Meteoric rises in HKD stock and MEGL stock have led some to declare a resurgence in meme stocks. Here's how you can profit.

Via InvestorPlace

ZYMERGEN ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of ZY and Encourages Investors to Contact the Firm

July 26, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sharps Compliance Corp. (Nasdaq - SMED), Infrastructure and Energy Alternatives, Inc. (Nasdaq - IEA), AutoWeb, Inc. (Nasdaq - AUTO), Zymergen Inc. (Nasdaq - ZY)

July 25, 2022

From Brodsky & Smith LLC

Via GlobeNewswire

Cathie Wood Loaded Up on Zymergen (ZY) Stock Before Ginkgo Buyout ↗

July 25, 2022

Zymergen shares are rallying after an all-stock buyout from Ginkgo Bioworks. Cathie Wood's Ark owns both DNA shares and ZY stock.

Via InvestorPlace

Zymergen (ZY) Stock Soars 20% on Acquisition News ↗

July 25, 2022

Zymergen finally received some much-needed good news when Ginkgo Bioworks agreed to buy out the firm, sending ZY stock soaring.

Via InvestorPlace

AAPL Stock: When Are Apple Earnings 2022? ↗

July 25, 2022

Investors in Apple (AAPL) stock are anxiously waiting for the company's upcoming earnings report, which is set to take place on Thursday!

Via InvestorPlace

Why Is Ginkgo Bioworks (DNA) Stock in the Spotlight Today? ↗

July 25, 2022

DNA stock is down even while Ginkgo Bioworks prepares to purchase a biotech business and a large research and development site.

Via InvestorPlace

WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

July 25, 2022

Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share...

Via Benzinga

5 Top Stocks Cathie Wood Bought This Week ↗

July 21, 2022

Shares of ARKK are up about 20% the past month as Cathie Wood continues her highly-convicted purchases of growth stocks.

Via InvestorPlace

7 Stocks Under $10 That Can Double in One Year ↗

July 19, 2022

These seven stocks under $10 have strong fundamentals and can bounce back by 100% from oversold levels in the next 12 months.

Via InvestorPlace

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.